0.0013 * 0.0014 Might have some upside in the coming days....
Posted by bksundar on :
0.0014 * 0.0015 Up 37% on 12M vol (av 10 day vol = 14m)
Posted by bksundar on :
0.0014 * 0.0016 Up 37% on 24.5M vol (av 10 day vol = 14m)
Posted by bksundar on :
0.0016 Up 46% on 31M vol (av = 14M)
Posted by bksundar on :
0.0017 Up 55% on close to 40M (av 10 day vol = 14M)
Posted by EverGreen on :
key # is .0018 - 50ma next res 0023 0026 0032 0072
Posted by bksundar on :
0.0018 (resistance point) up 64% on 40.7M vol
Posted by bksundar on :
Game for today look like it is over at 0.0018 resistance/50ma... Not a bad play for today
1st day of really good upward price action in a long time since beginning of the year
Posted by Upside on :
quote:Originally posted by bksundar: Might have some upside in the coming days....
Not if I have anything to say about it. Posted by bksundar on :
quote:Originally posted by Upside:
quote:Originally posted by bksundar: Might have some upside in the coming days....
Not if I have anything to say about it.
LOL....
Posted by bksundar on :
quote:Originally posted by EverGreen: key # is .0018 - 50ma next res 0023 0026 0032 0072
As soon as you posted that, it touched 0.0018 and backed off.
This board is great in pointing these things out..
Good work....
Posted by EverGreen on :
numbers never lie
no need to break today - a close at 0015-16 i good enough
(but next time i bluff and write 0028 LOL)
quote:Originally posted by bksundar:
quote:Originally posted by EverGreen: key # is .0018 - 50ma next res 0023 0026 0032 0072
As soon as you posted that, it touched 0.0018 and backed off.
This board is great in pointing these things out..
Good work....
Posted by bksundar on :
0.0011 to 0.0018 back to 0.0012 !!!! What a ride....
Posted by RCAnalyst2007 on :
merhaba sundar,,
I'm in MGEN now..
Posted by bksundar on :
quote:Originally posted by RCAnalyst2007: merhaba sundar,,
I'm in MGEN now..
I think Homer said something of increase in AS Not goog for MGEN I hate dilution
Posted by EverGreen on :
going for a big run
Paradigm Medical Industries, Inc. (OTCBB: PMED.OB/PMEDW.OB), the leader in glaucoma diagnostic and management devices, today disclosed it has received an order for 30 Dicon LD400 Visual Fields Analyzers (Perimeters) from one of the largest optical chains in the United Kingdom. The retail value of this order exceeds $250,000. Delivery is scheduled by the end of this year. The LD400 AutoPerimeter is used to measure patient visual fields to determine the severity of glaucoma and to aid in managing the disease. "This is a significant acceptance of the fact that our LD400 with its patented Kinetic Fixation feature is the most technically advanced Perimeter available today," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax. "Though the LD400 is in the midst of a major technology upgrade, it is obvious that Paradigm Medical's existing VFA technology is superior." The Company noted that it already has received written commitments for an additional 40-50 LD400 Perimeters from the same UK optical chain, which will also be delivered during the first quarter of 2008. The total retail value of all shipments would exceed $600,000. Paradigm Medical Industries, Inc., is the leader in Ultrasound devices, and glaucoma detection and management products.
Posted by rvenza1 on :
up we go
Posted by JimSC on :
Watch this one for the next 3 weeks.
Posted by IMAKEMONEY on :
Next resistance is supposed to be 0.0032
Posted by RWGATORBLUE on :
Reminds me of GSNH yesterday. Resistance around .0032 and once there it just went to .006. I got out at .004. Get in on this now.
Posted by EverGreen on :
done
and next is .0042 (where is HDSN ...)
quote:Originally posted by bksundar: Next resistance is supposed to be 0.0032
Posted by bksundar on :
Thanks Evergreen You are the man.... Like clockwork, it touches you resistance points and retraces a bit before the next move...
Posted by RWGATORBLUE on :
This thing wants to go to .004 but the money is small. What the heck is a 5000 share buy *.003, 15 bucks?
Posted by RWGATORBLUE on :
Sell now and you'll be sorry.
Posted by EverGreen on :
until now it follows perfectly the chart
hope will continue (there is DOMS at 0035)
quote:Originally posted by bksundar: Thanks Evergreen You are the man.... Like clockwork, it touches you resistance points and retraces a bit before the next move...
Posted by bksundar on :
Looks like 0.0033 is the resistance for the day/month...
Posted by RWGATORBLUE on :
What the heck happened?
Posted by RWGATORBLUE on :
On the way back again guys. GET ON BOARD!
Posted by bksundar on :
What do expect when a stock rises from 0.000s to 0.0033 ?? It is like a stock going from 1 to 33 in a few days.. It will retrace to the 20s. Even high teens for a healthy move later....
Posted by RWGATORBLUE on :
This will end at around .0035 by end of the day. Wish I had more money to put in it.
Posted by bksundar on :
The main resistance at 0.0033 Then next stop in the 0.004s
Posted by RWGATORBLUE on :
There it goes.
Posted by bksundar on :
What do you mean ? It is stuck at 0.0027 * 0.003
Posted by JimSC on :
We are heading to the next leg. Got a good consolidation today.
More news and contracts expected in the next few weeks.
They just sold $250,000 worth of medical equipment to a distributor in England 2 weeks ago.
Even if it reaches 0.01 to 0.02 I will be ecstatic with my 2m shares at 0.0015
Posted by bksundar on :
Looks like today is the day for profit taking and day trading on this stock. Struggling after a 0.003 touch...
Posted by oldguy on :
One order for $250,000 is not bad. I am sure they are working on more like that or even better. If we are able to break the .0033 barrier, this one will get to at least .007 IMO. It might not require more news to get there. If we get more news like the last, then we might see penny land. I am speculating that today was a profit taking day. I will take the modest gain, though. Just got in this one yesterday at .0015. I am learning to stay away from the.0001 and .0002 stocks and pay a little more when the stock gets above .001 (pay a little more and catch it on its way up) We'll see.
Posted by IMAKEMONEY on :
Posted by EverGreen on :
is trying again to break .0032 (and then booooom)
Posted by oldguy on :
I am not running scared and selling right now. The lull in activity may just be very short term. This should still run on the recent news and outstanding potential this company has. I am guessing there are more opportunities for sales in England as well as in other countries.
Posted by JimSC on :
Many investors got in between 0.0007 and 0.0014, and they wanted to lock in the profits for the weekend. I am planning to add more before closing. I expect more PRs and contracts shortly after the new year. PMED has a history of good runs at this time of the year, especially after she hits the bottom. Good luck.
Thanks Jim. I am new to PMED. I was in on the last run with RSHN and with USXP, but sold a little too early.
Posted by jrtfan on :
I just added more at .0022 only a partial, but at that price, I'm not complaining.
Posted by JimSC on :
quote:Originally posted by jrtfan: I just added more at .0022 only a partial, but at that price, I'm not complaining.
I hope the MMs will take it down more, and make it bounce back really hard when the PR comes out next week. Just watch it.
Posted by bksundar on :
Same here hoping for the high teens for more pick up !!!
Posted by JimSC on :
Looks like 0.0023 is the bottom.
This may not attract many new investors, one more down day is expected.
Posted by JimSC on :
PMED: 0.0021
Market Cap: 800 K$ Projected rev for 2008: 4 M$
The CEO said:
* We have become more globally oriented with our U.S. and international regulatory-approved products. And we have already established foot prints in the fastest-growing regions of the world, namely Asia and East Europe. A major part of this success has been the establishment of partnerships with leading developers and producers of ultrasound devices like China’s MEDA Co. Ltd., and new-generation software with innovative companies like Reliacon Global (San Ramon, CA).
* We have strengthened the Company’s financial structure with the completion of several fundings, completed in 2005 and 2006, that have allowed us to upgrade our facilities and further advance our research and development programs.
* Specifically, the Company will be entering a fast-track path in revenue and margin growth. By the end of 2008, our goal is to be at an annualized revenue run-rate of $4 million. We believe gross profit margin will be at least 50% (likely higher), which would result in gross profit of $2 million.
* More importantly, our goal is to be slightly cash flow positive by the end of 2008. Again, this will reflect a dramatic improvement from our recent year “negative” cash flows. We view our cash flow performance as one of the true benchmarks of determining the success of our corporate goals.
* During the next 24 months the Company’s goal is to reach annualized sales of $5 million, and gross profit of $2.75 million. Management is committed to maintaining an indirect expense level of $2.5 million during that timeframe. At such performance levels, Paradigm Medical would generate a modest profit from operations and achieve consistently positive cash flow.
Posted by JimSC on :
0.0017 - watch it.
It could bounce from here.
Posted by tmanfromtexas on :
.0014/.0015, it bounced off the cliff. lol. some nice 7 figure buys coming in though. It may end up near the high if that keeps up. TMAN...
Posted by JimSC on :
Did add some at 0.0015.
Just play along with the MMs.
So we got a big take-down and big volume today -- the run should come soon.
Happy new year.
*****
Time & Sales Price Size Exch Time 0.0017 200000 OBB 15:30:19 0.0015 1000000 OBB 15:28:43 0.0014 8000000 OBB 15:28:30 ***** 0.0014 9000000 OBB 15:28:30 **** 0.0015 400000 OBB 15:28:25 0.0015 500000 OBB 15:28:25 0.0015 400000 OBB 15:27:36 0.0015 200000 OBB 15:27:27 0.0015 700000 OBB 15:27:07 0.0015 650000 OBB 15:26:02 0.0015 2000000 OBB 15:25:47 0.0015 300000 OBB 15:24:33 0.0015 400000 OBB 15:24:21 0.0015 1250000 OBB 15:24:12 0.0015 500000 OBB 15:21:44 0.0016 500000 OBB 15:20:15 0.0015 500000 OBB 15:20:15 0.0015 575000 OBB 15:20:11 0.0015 150000 OBB 15:19:45 0.0015 400000 OBB 15:19:34 0.0015 900000 OBB 15:18:59 0.0016 300000 OBB 15:18:53 0.0016 206800 OBB 15:18:53 0.0016 138400 OBB 15:18:53 0.0016 132264 OBB 15:18:53 0.0016 116500 OBB 15:18:53 0.0015 900000 OBB 15:18:52 0.0015 800000 OBB 15:18:03 0.0015 800000 OBB 15:18:00 0.0015 5500 OBB ****** One MM has collected 17 M shares. So the collection phase is almost done. They will gradually push the PPS up to unload their shares. Watch it.
Posted by tmanfromtexas on :
You too Jim. Hope we all make some green in '08. TMAN...
Posted by JimSC on :
Date Open High Low Last Change Volume % Change 01/02/08 0.0020 0.0020 0.0016 0.0017 -0.0001 4128500 -5.56% 12/31/07 0.0024 0.0024 0.0014 0.0018 -0.0003 54720199 -14.29% 12/28/07 0.0029 0.0030 0.0021 0.0021 -0.0006 23144801 -22.22% 12/27/07 0.0024 0.0033 0.0022 0.0027 +0.0004 58962203 +17.39% 12/26/07 0.0013 0.0024 0.0012 0.0023 +0.0011 71627508
Posted by Bottomfeeder on :
yup,thats where I bought I can see.Glad it wasnt a bundle like sum others.
Posted by EverGreen on :
Paradigm Medical Industries, Inc. (OTCBB: PMED.OB), the leader in glaucoma diagnostic and management devices, today announced it has completed the funding of $1 million through a group of institutional investors, headed by NIR Group (New York). A significant portion of the proceeds will be used to fund the introduction, marketing and distribution of new ophthalmic instruments and systems the Company plans to launch during the first half of 2008. "We will also use proceeds to grow our domestic sales force, to increase direct and distributor sales force training, and to increase inventories," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax. "Marketing our redesigned LD 400 Visual Fields and Blood Flow Analyzer(TM) (BFA) products and introducing new devices and systems into the ophthalmic market is one of our primary areas of focus in 2008." Mr. Cannefax noted the Company already is filling a significant order for LD 400s for one of the largest optical chains in the United Kingdom, and has written commitments for additional LD 400 Perimeters from the same chain. "We had a threefold increase in our sales organization in late 2007 and will have a presence in additional metropolitan areas. The new funding will allow us to introduce new and updated diagnostic products and have a trained and highly competent sales force to market and distribute them in 2008," Mr. Cannefax added. The funding involves the purchase of $1,000,000 in secured convertible notes by the investing group. The notes are to be purchased in traunches, with the first traunche of $250,000 and then monthly traunches of $100,000 each until a total of $1,000,000 in notes have been purchased. Paradigm Medical received the first $250,000 upon the signing of definitive agreements on December 24, 2007. The Company also is required to issue warrants to the noteholders to purchase a total of 15,000,000 shares of common stock at an exercise price of $0.001 per share. Under the terms of the notes, the unpaid principal balance on the notes, together with accrued interest at 8% per annum, is due in three years from the date of issuance. The notes are also convertible by the noteholders at any time into shares of common stock. The conversion price of the notes is equal to the lesser of (i) $0.02 and (ii) the average of the lowest intra-day trading prices during the 20 trading days immediately prior to the conversion date discounted by 50%.
Posted by jrtfan on :
Moving up on the news.
Posted by JimSC on :
More PRs about sale numbers expected during the next few weeks. Hold your shares tight for more good news.
*** From Ihub:
Posted by: bucksmypup In reply to: Neocheeseater who wrote msg# 2079 Date:1/2/2008 3:26:07 PM Post #of 2081
1st reading the financing is not the greatest but then again thinking about it. 2 million in sells and they can pay it off. they have stated they now have about a 50% profit margin. The total of the last order is about 600k with annual sales of about 5 million. This is just the beginning folks and its not terrible toxic. We will be fine and we now have a line of credit for 1 million. Looking very good. Here comes .01st05 maybe even .01 1st quarter. JMHO
Posted by oldguy on :
This company is doing what real companies do. Borrow money to get their product information out and then sell their product. I have found that the two best times to market your product is when: you are busy and when you are not busy. I like PMED.
Posted by JimSC on :
From IHub: ***** Posted by: bucksmypup In reply to: FastEddie777 who wrote msg# 2098 Date:1/2/2008 4:39:31 PM Post #of 2100
I honestly believe there is more news coming. NO one expected this. I think we still will get delivery news, then hopefully additional sales. They are increasing inventories presently and adding sales people. This is just the beginning. This stock is easily going to .01 this year. JMHO
Posted by bksundar on :
I hope it reaches 0.003 today and then beyond 0.004 sometime during Jan
Posted by Andreas on :
bk, looks more like it is going the other way right now Posted by jdiddy on :
its coming down so I can get in..lol..j/k
Posted by bksundar on :
Yep sure looks like it.... Anyway I play pinkies rarely these days.... When stocks like SOLF, ASTI, LDK MELI etc give better returns...
Posted by JimSC on :
I expect more consolidation and more shakes, but eventually the pps will be much higher because the MMs want that way so they can unload their shares. This will happen when PMED release more sale numbers. In the mean time set your targets at different levels. Give the MMs 4 weeks to play.
Posted by bksundar on :
I hope so. This is my wild card Really wild....
Posted by JimSC on :
All pink/Otc stocks are for gamble only. It's not a good idea to play too wild for a particular one.
*****
PMED: 0.0019 -- the market is expecting some good sale numbers next week.
Hope it crosses into the 0.002s today...
Posted by Bottomfeeder on :
You mean above .01
Posted by JimSC on :
Some investing company has taken the risk of 1 M$ for PMED. So just gamble 200 with a potential pay off of 5X to 10X. This is a good gamble. I expect more PRs and sale contracts in the next two weeks. To win the game, you need to get in early and never chase the run.
**** From Ihub - about the new 8K:
Posted by: fillinggood In reply to: None Date:1/7/2008 9:32:03 AM Post #of 2197
What's good is what is implied in the stipulations IMHO. The financiers are limited to the amount of shares they can obtain by note conversion to under 5% of the company's outstanding shares, so as the stock price would rise, they could not accumulate a number of cheaper shares that would result in company ownership thru stock. this protects the company and us in our pps. Also, they now have prepayment stipulations on the loan which means that PMED feels they will have a good enough sales and profits to pay loans off early. This is all good news for the company and us IMHO.
Posted by JimSC on :
okay we need to break into the 2s today
Posted by jdiddy on :
.002
Posted by JimSC on :
Level 2 - Asks:
MM ID Ask Size Time SBSH 0.0020 50 10:06:01 NITE 0.0020 50 09:50:02 HDSN 0.0023 5000 15:36:22 MAXM 0.0023 50 07:30:10 DOMS 0.0024 50 07:30:10 HILL 0.0024 50 07:30:10 SALI 0.0024 50 07:30:10 PERT 0.0026 50 07:30:10 ETRD 0.0027 50 10:15:00 VNDM 0.0035 50 07:30:10 UBSS 0.0036 50 07:48:07 BEST 0.0036 50 07:56:35 VFIN 0.0050 50 07:30:10
Posted by jdiddy on :
looking good Jim....002's on the way
Posted by JimSC on :
Very good consolidation. Just give PMED 2 more weeks; waiting for the news of another big order. *** Time & Sales Price Size Exch Time 0.0019 160000 OBB 11:20:01 0.0019 50000 OBB 11:01:16 0.002 45000 OBB 10:20:32 0.0017 1016700 OBB 10:06:20 0.0018 450000 OBB 10:05:58 0.0018 500000 OBB 10:04:59 0.0018 5000 OBB 10:04:53 0.0019 200000 OBB 10:04:31 0.0019 250000 OBB 09:49:59 0.0018 300000 OBB 09:49
Posted by biker0962 on :
anyone got some jumper cables, need to get this stock moving-LOL
Posted by jdiddy on :
jumpstart in reverse.. i feel an update coming
added 300k at .0015
Posted by biker0962 on :
overall the market is tough right now, but looking at the charts, id say we might be in for another dip in price, so if it dips say to about .0013 I will load up again, but lets keep our fingers crossed, cuase im usually wrong-LOL
Posted by EverGreen on :
Paradigm Medical Industries, Inc. (OTCBB: PMED), a leader in glaucoma diagnostic and management devices, disclosed today it has entered into a consulting agreement with Corcoran Consulting Group (San Bernardino, CA). Terms were not disclosed. Corcoran Consulting Group (CCG) specializes in medical reimbursement issues for optometry and ophthalmology. Kevin Corcoran, president of CCG, is recognized as a leading expert in the field of medical billing. CCG will provide a variety of services for Paradigm Medical, including training, seminars, publications, and telephone and trade show support. "We will be working closely with CCG to create new category codes for our Blood Flow Analyzer(TM) (BFA), as well as offering educational seminars for physicians and practitioners," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax. "We are pleased to be working with Kevin Corcoran and his team, and expect CCG to enhance Paradigm Medical's product offerings and market presence." BFAs are used by doctors in their patient evaluation and management of glaucoma and pressure related to eye ailments. CCG may also provide services designed at creating greater industry acceptance and recognition of Paradigm Medical's P60 Ultrasound BioMicroscope (UBM).
Posted by biker0962 on :
hmmmmm sounds nice, is this company listed in the pinks and if so PLEASE tell me Im not looking at another R/S merger-LOL
Posted by Lockman on :
I think they just recently had an R/S under a different symbol.
Posted by live2trade on :
Lockman,
No R/S has ever been involved with this company. They have not been under a different name either. Pinksheets would have had it listed. These guys are running some good progress and will be profitable IMO.
Posted by live2trade on :
Go back on SEC filings since 2005 it has always been pmed. Again NO R/S has been done or will be done by the company. Take it for what its worth.
Posted by jdiddy on :
Paradigm Medical Industries Settles Last of Active LawsuitsLast update: 1/23/2008 9:50:01 AMSALT LAKE CITY, Jan 23, 2008 (BUSINESS WIRE) -- Paradigm Medical Industries, Inc. (PMED), a leader in glaucoma diagnostic and management devices, announced today it has settled the last of its currently active lawsuits against the Company. The Company disclosed it had reached an out-of-court settlement with Larry Hicks, a former consultant. Terms were not disclosed. In 2006, Paradigm Medical resolved two suits filed by former employees via summary judgments in favor of the Company. Paradigm Medical also resolved several class-action suits out of court in 2005. All of these lawsuits, including Hicks and the class action suits, were filed in 2003. "We can now fully concentrate on our core business of developing, manufacturing and marketing of diagnostic glaucoma equipment that we provide to the ophthalmic industry," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax. "Management has spent substantial time defending the Company in these suits. We can now have full focus in implementing our strategies and business plan." Paradigm Medical Industries, Inc., is a leader in Ultrasound devices, and glaucoma detection and management products. This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements. SOURCE: Paradigm Medical Industries, Inc. Paradigm Medical Industries, Inc.Joy Roop, 801-977-8970Copyright Business Wire 2008
Posted by jdiddy on :
up 30%
Posted by jdiddy on :
.0015 x .0016
Posted by jdiddy on :
.0016 x .0017
Posted by jdiddy on :
2x3 looking better nice volume lets gooooooooooo!!
Posted by jdiddy on :
.0017's falling
Posted by JimSC on :
I hope more sale orders will be coming soon.
Looks like the MMs have accumulated enough shares for a run.
Posted by jdiddy on :
.0018's up
aah Jim your back....lol
Posted by Andreas on :
Got some at .0015
Posted by JimSC on :
quote:Originally posted by jdiddy: .0018's up
aah Jim your back....lol
I trust the MMs -- they will make a big run of PMED after a few days of consolidation. The huge volume will help the run, too. See this great chart:
*** Posted by: bucksmypup In reply to: Investolator who wrote msg# 2447 Date:1/23/2008 1:59:51 PM Post #of 2448
I believe Pmed is setting this up for some more good news soon. Not sure what or when but, we now have no lawsuits, we have agreements with consultants, We have sales and we have funding. Things looking pretty good here if u ask me. I still think .005 is very achievable with another decent order. I just hope we get news of this soon. NOt saying there is an order out there just hoping. Glta.
Posted by jdiddy on :
.001 POS
Posted by JimSC on :
A big take-down before the run? Looks like IVOI and IVOT before the big runs. The MMs are loading at this level, while many members of the Ihub are frustrated and giving up.
Posted by jdiddy on :
im still here jim Posted by biker0962 on :
been in this one to long-lol
Posted by jdiddy on :
up 27% keep going
Posted by jdiddy on :
Paradigm Medical Industries to Market Proprietary Electrophysiology Device for Early Detection of Glaucoma Company Signs Exclusive Distribution Agreement With Italy's LACE ELETTRONICA Jan 28, 2008 9:39:00 AM Copyright Business Wire 2008
View Additional Profiles
SALT LAKE CITY--(BUSINESS WIRE)--
Paradigm Medical Industries, Inc. (OTCBB: PMED.OB), a leader in glaucoma diagnostic and management devices, disclosed today it has signed an exclusive agreement with LACE Elettronica srl (Rome, Italy) to distribute the latter's proprietary GLAID electrophysiology instrument for the early detection of glaucoma. Terms were not disclosed.
LACE's GLAID is a revolutionary diagnostic device that utilizes Pattern Electroretinogram (PERG) to provide a visual stimulus that generates electrical responses of the retina to measure the physical condition of the retina's ganglion cells. Retinal ganglion cells collectively transmit visual information from the retina to several regions in the midbrain. There are about 1.2-1.5 million retinal ganglion cells in the human retina. The GLAID device was approved by the U.S. Food and Drug Administration (FDA) in 2007.
The GLAID device has undergone extensive testing and clinical studies in the U.S., Canada and Italy, including Bascom Palmer Eye Institute (Miami and Palm Beach, FL), University of California at San Diego's Hamilton Glaucoma Center, New York State College of Optometry, University of Laval (Quebec, Canada), and the University of Alabama. The current state of the GLAID technology was developed by Dr. Vittorio Porciatti, who is also involved in further GLAID-related research at Bascom Palmer Eye Institute.
"We believe the GLAID device is the most significant development in glaucoma detection in the last 20 years," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax. "It represents a multimillion-dollar market opportunity for our Company."
"We are pleased to be working with Paradigm Medical in introducing and promoting GLAID," said Alessio Romani, chief executive of LACE. "The Company is well known and respected for its glaucoma diagnostic devices. The agreement is expected to accelerate acceptance of the GLAID technology in North America and Canada in 2008."
"The GLAID device is believed to be the fastest method of testing for retinal ganglion cell loss," Mr. Cannefax noted. "The GLAID not only measures dead and living ganglion cells, but also detects ailing ganglion cells. Due to the device's ability to detect dying ganglion cells, in most cases the viability of these cells can be fully restored with treatment."
Mr. Cannefax added that "GLAID provides a test that is fast and easy to understand and administer, easy to interpret by the clinician, and is non-invasive. It is reliable, operator independent, and is able to detect dysfunction of the ganglion cells in patients who are glaucoma suspects. GLAID can detect the onset of retinal defects significantly earlier than can be measured by the current standard of detection method of Visual Fields Analysis (Perimeters). We expect to begin filling orders during the first quarter of 2008."
Glaucoma, caused by deterioration of the optic nerve and related ganglion cells, is the second leading cause of permanent vision loss. It affects one in five people over age 50. Some 75% of glaucoma goes undiagnosed because of the lack of sophisticated instrumentation. There are more than 64 million cases of glaucoma worldwide, including more than three million in the U.S. About 120,000 people in this country are blind as a result of glaucoma. Nearly 16,000 surgeries are performed in the U.S. each year on patients with glaucoma, with the cost averaging about $3,200, depending on the severity of the glaucoma. In terms of Social Security benefits, loss of income tax revenues and health-care expenditures, the cost to the U.S. government related to glaucoma is estimated to be more than $1.5 billion annually.
Paradigm Medical Industries, Inc., is a leader in Ultrasound devices, and glaucoma detection and management products.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risks and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
Source: Paradigm Medical Industries, Inc.
---------------------------------------------- Paradigm Medical Industries Inc. Joy Roop 801-977-8970 www.paradigm-medical.com Posted by JimSC on :
Paradigm Medical Industries Introduces Advances on the LD400 Full-Field Autoperimetry System Wednesday March 5, 4:42 pm ET
SALT LAKE CITY--(BUSINESS WIRE)--Paradigm Medical Industries, Inc. (OTCBB: PMED.OB - News), a leader in glaucoma diagnostic and management devices, is introducing new advance developments to the Paradigm-Dicon LD400 full-field autoperimetry system. The LD400 is used to measure patient visual fields to determine the severity of glaucoma and to aid in managing the disease. ADVERTISEMENT
“The Company has redesigned what we believe to be the industry’s superior autoperimeter,” said Paradigm Medical’s Chief Executive Officer, Raymond Cannefax. “Demand for our proprietary Paradigm-Dicon LD400 product continues to be extremely high in the U.S. and globally, and this updated product incorporates all the changes the medical profession has requested. We believe we are also broadening the market for autoperimeters.
“The kinetic fixation feature of the LD400 Autoperimeter is unique and exclusive to perimetry and offers full kinetic fixation for greater reliability, improved test results and patient comfort,” Mr. Cannefax added. “Kinetic fixation reduces patient fatigue and increases patient interest resulting in higher exam accuracy. The Paradigm-Dicon LD400 provides the highest standard of care from a full-field autoperimeter.”
New developments to the LD400 include redesigning the existing software, assuring device compatibility with a variety of printers and making the device fully networkable. All connections will be through USB ports. The patient data base will be similar to the Paradigm P60 Ultrasound BioMicroscope (UBM) and the printed examination reports will be grayscale, making them much easier to read.
Paradigm Medical Industries, Inc., is a leader in Ultrasound devices, and glaucoma detection and management products.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainty and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
-------------------------------------------------------------------------------- Source: Paradigm Medical Industries, Inc.
Posted by Wino Ph.D. on :
More news and lots of volume so far this morning.
Paradigm Medical Industries to Introduce Early Glaucoma Detection Device at ASCRS Conference Tuesday March 11, 9:22 am ET
SALT LAKE CITY--(BUSINESS WIRE)--Paradigm Medical Industries, Inc. (OTCBB: PMED.OB - News), said today it will introduce the Glaid-PERG electrophysiology instrument for the early detection of glaucoma at the American Society for Cataract Refractive Surgeons (ASCRS) Conference in Chicago, IL, next month.
“All research and studies indicate the Glaid-PERG diagnostic device is the earliest means of detecting cellular losses attributed to glaucoma and other ocular ailments,” said Paradigm Medical’s Chief Executive Officer, Raymond Cannefax. The Company signed an exclusive agreement with LACE Elettronica srl (Rome, Italy) to distribute the Glaid-PERG instrument earlier this year.
After many years of clinical studies at major U.S. and European glaucoma centers, as well as at universities and research centers, the Glaid-PERG has proven to provide high test repeatability and a high level of accuracy. Ongoing research is indicating testing application for ocular ailments other than glaucoma.
“We are excited about the impact the new instrument will have—not only in our industry, but in medical benefits to those who will be diagnosed early as glaucoma suspects,” Mr. Cannefax added. “Early diagnosis will help reduce vision loss and help preserve sight. This is a logical progression in the early detection of glaucoma, the world’s major contributor to vision loss.”
Paradigm Medical will also introduce the prototype version of its redesigned LD400 Autoperimetry system at the ASCRS show. The LD400 is used to measure patient visual fields to determine the severity of glaucoma and to aid in managing the disease.
“The introduction of these two devices is further indication of our Company’s leading technology in eye care,” Mr. Cannefax noted. “It is all part of our ‘Continuous Improvement’ commitment.”
Paradigm Medical Industries, Inc., is a leader in Ultrasound devices, and glaucoma detection and management products.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainty and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
![[Big Grin]](biggrin.gif)
![[Wink]](wink.gif)
![[Smile]](smile.gif)
![[Frown]](frown.gif)
![[Good Luck]](graemlins/goodluck.gif)